You are here

  • Home
  • Archive
  • Volume 31, Issue 11
  • ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)

Article metrics

Article menu

Download PDFPDF

Clinical trial
ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)

 

Online download statistics by month:

Online download statistics by month: September 2021 to July 2022

AbstractFullPdf
Sep 2021456455166
Oct 2021383373119
Nov 2021728726135
Dec 2021748740523
Jan 202213171313949
Feb 2022135813461146
Mar 202233733079
Apr 2022116311661066
May 2022174917451518
Jun 2022133813441093
Jul 202225254
Total960295636798